CN Patent

CN107108588A — 可用于治疗癌症的稠合双环(杂)芳香族化合物

Assigned to Jazz Pharmaceuticals Inc · Expires 2017-08-29 · 9y expired

What this patent protects

本发明涉及新颖的化合物。本发明的化合物是激酶抑制剂。具体地，本发明的化合物可用作Raf激酶例如B‑Raf和C‑Raf的抑制剂。本发明还预期该化合物用于治疗通过抑制Raf激酶可治疗的状况的用途，所述状况例如癌症、肉瘤、黑色素瘤、皮肤癌、血液肿瘤、淋巴瘤、上皮癌和白血病。

USPTO Abstract

本发明涉及新颖的化合物。本发明的化合物是激酶抑制剂。具体地，本发明的化合物可用作Raf激酶例如B‑Raf和C‑Raf的抑制剂。本发明还预期该化合物用于治疗通过抑制Raf激酶可治疗的状况的用途，所述状况例如癌症、肉瘤、黑色素瘤、皮肤癌、血液肿瘤、淋巴瘤、上皮癌和白血病。

Drugs covered by this patent

Patent Metadata

Patent number
CN107108588A
Jurisdiction
CN
Classification
—
Expires
2017-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.